{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:07:20Z","timestamp":1790633240360,"version":"4.1.0"},"reference-count":23,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,18]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The terms clonal monocytosis of undetermined significance (CMUS) and clonal cytopenia and monocytosis of undetermined significance (CCMUS) were introduced by the International Consensus Classification of Myeloid Neoplasms to describe cases of clonal hematopoiesis (CH) and concurrent monocytosis that did not meet the diagnostic criteria of chronic myelomonocytic leukemia. To date, their practical relevance as clinicopathological entities at a population level has not been assessed. Here, we assess the prevalence, significance, and natural history of CMUS and CCMUS among 431\u2009531 UK Biobank participants through analysis of clinical, genomic, and health outcome data. We find that CMUS with an absolute monocytosis and CCMUS are high-risk entities strongly associated with incident myeloid neoplasia (MN), cardiovascular disease, and renal disease. Noting the overall higher monocyte counts in men and the low rate of progression of DNMT3A-CMUS, we reveal that amending the definition of CMUS\/CCMUS to incorporate sex-specific monocyte thresholds and the exclusion of isolated DNMT3A mutations from the definition significantly strengthens the association with incident MN. Finally, given their association with poor outcomes, we develop MoSAIC, a machine-learning classifier, to infer the presence of SRSF2 mutations (associated with high MN risk) among individuals with monocytosis, based on complete blood count indices alone. We corroborate our findings in an independent cohort of 625\u2009328 Danish primary care patients. Our findings underscore the clinical relevance of CMUS and CCMUS as distinct high-risk states within the spectrum of CH and establish an evidence base to refine their diagnostic definition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031883","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T18:02:37Z","timestamp":1773079357000},"page":"3039-3050","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["The prevalence and clinical significance of clonal monocytosis"],"prefix":"10.1182","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-5198","authenticated-orcid":false,"given":"William G.","family":"Dunn","sequence":"first","affiliation":[{"name":"1Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom"},{"name":"3Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8676","authenticated-orcid":false,"given":"Michael C.","family":"Sachs","sequence":"additional","affiliation":[{"name":"4Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Maggi","sequence":"additional","affiliation":[{"name":"5Department of Molecular Medicine, University of Pavia, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxin","family":"Gu","sequence":"additional","affiliation":[{"name":"1Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom"},{"name":"2Department of Haematology, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7793-6291","authenticated-orcid":false,"given":"Pedro M.","family":"Quiros","sequence":"additional","affiliation":[{"name":"6Department of Biochemistry and Molecular Biology, Instituto Universitario de Oncolog\u00eda, Universidad de Oviedo, Oviedo, Spain"},{"name":"7Cancer Research Division, Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-0979","authenticated-orcid":false,"given":"Kiran","family":"Batta","sequence":"additional","affiliation":[{"name":"8Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christen Lykkegaard","family":"Andersen","sequence":"additional","affiliation":[{"name":"9Research Unit for General Practice, Department of Public Health, University of Copenhagen, Copenhagen, Denmark"},{"name":"10Department of Hematology, University Hospital Copenhagen, Rigshospitalet, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete A.","family":"Fabre","sequence":"additional","affiliation":[{"name":"2Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"3Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom"},{"name":"11Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8672-1906","authenticated-orcid":false,"given":"Timothy","family":"Chevassut","sequence":"additional","affiliation":[{"name":"12Department of Clinical and Experimental Medicine, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4863-761X","authenticated-orcid":false,"given":"Irina","family":"Mohorianu","sequence":"additional","affiliation":[{"name":"1Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0715-1402","authenticated-orcid":false,"given":"Daniel H.","family":"Wiseman","sequence":"additional","affiliation":[{"name":"7Cancer Research Division, Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias, Oviedo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-8022","authenticated-orcid":false,"given":"George S.","family":"Vassiliou","sequence":"additional","affiliation":[{"name":"1Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom"},{"name":"2Department of Haematology, University of Cambridge, Cambridge, United Kingdom"},{"name":"3Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"26","key":"2026061811221544700_bib1","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"2026061811221544700_bib2","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"2026061811221544700_bib3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"8","key":"2026061811221544700_bib4","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","article-title":"Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis","volume":"10","author":"McKerrell","year":"2015","journal-title":"Cell Rep"},{"issue":"2","key":"2026061811221544700_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"2026061811221544700_bib6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41591-024-02854-6","article-title":"Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury","volume":"30","author":"Vlasschaert","year":"2024","journal-title":"Nat Med"},{"issue":"7714","key":"2026061811221544700_bib7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","article-title":"Prediction of acute myeloid leukaemia risk in healthy individuals","volume":"559","author":"Abelson","year":"2018","journal-title":"Nature"},{"issue":"9","key":"2026061811221544700_bib8","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41588-023-01472-1","article-title":"Multiparameter prediction of myeloid neoplasia risk","volume":"55","author":"Gu","year":"2023","journal-title":"Nat Genet"},{"issue":"5","key":"2026061811221544700_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200310","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"2","author":"Weeks","year":"2023","journal-title":"NEJM Evid"},{"issue":"19","key":"2026061811221544700_bib10","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2024024756","article-title":"Risk prediction for clonal cytopenia: multicenter real-world evidence","volume":"144","author":"Xie","year":"2024","journal-title":"Blood"},{"issue":"suppl 1","key":"2026061811221544700_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1182\/blood-2024-203837","article-title":"High-risk Ccus is clinically indistinguishable from low-risk myelodysplastic syndromes\/neoplasms","volume":"144","author":"Xie","year":"2024","journal-title":"Blood"},{"issue":"11","key":"2026061811221544700_bib12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"12","key":"2026061811221544700_bib13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2018-08-867333","article-title":"The use of targeted sequencing and flow cytometry to identify patients with a clinically significant monocytosis","volume":"133","author":"Cargo","year":"2019","journal-title":"Blood"},{"issue":"14","key":"2026061811221544700_bib14","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1182\/bloodadvances.2021006755","article-title":"Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals","volume":"6","author":"van Zeventer","year":"2022","journal-title":"Blood Adv"},{"key":"2026061811221544700_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/CLEP.S437123","article-title":"The Copenhagen Primary Care Laboratory (CopLab) database","volume":"16","author":"Kriegbaum","year":"2024","journal-title":"Clin Epidemiol"},{"issue":"7819","key":"2026061811221544700_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-020-2430-6","article-title":"Monogenic and polygenic inheritance become instruments for clonal selection","volume":"584","author":"Loh","year":"2020","journal-title":"Nature"},{"issue":"446","key":"2026061811221544700_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"9","key":"2026061811221544700_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v102.i09","article-title":"Event history regression with pseudo-observations: computational approaches and an implementation in R","volume":"102","author":"Sachs","year":"2022","journal-title":"J Stat Softw"},{"issue":"7","key":"2026061811221544700_bib19","doi-asserted-by":"crossref","first-page":"e70169","DOI":"10.1002\/hem3.70169","article-title":"CHIC: a machine learning framework for inferring the presence of high-risk clonal hematopoiesis using complete blood count data from 431,531 UK Biobank participants","volume":"9","author":"Dunn","year":"2025","journal-title":"HemaSphere"},{"issue":"7","key":"2026061811221544700_bib20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"12","key":"2026061811221544700_bib21","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/leu.2017.164","article-title":"Genomic determinants of chronic myelomonocytic leukemia","volume":"31","author":"Patel","year":"2017","journal-title":"Leukemia"},{"issue":"8","key":"2026061811221544700_bib22","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","article-title":"Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis","volume":"54","author":"Kar","year":"2022","journal-title":"Nat Genet"},{"issue":"6","key":"2026061811221544700_bib23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.kint.2024.07.036","article-title":"Clonal monocytosis of renal significance","volume":"106","author":"Natu","year":"2024","journal-title":"Kidney Int"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/25\/3039\/2528323\/blood_bld-2025-031883-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/147\/25\/3039\/2528323\/blood_bld-2025-031883-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:22:24Z","timestamp":1781796144000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/147\/25\/3039\/567022\/The-prevalence-and-clinical-significance-of-clonal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":23,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2026,6,18]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031883","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,18]]},"published":{"date-parts":[[2026,6,18]]}}}